Physiological Effect of Ataulfo Mango (Manguifera Indica) Beverage in Exercise

June 7, 2017 updated by: Universidad Autonoma de Ciudad Juarez

Physiological Response to Ataulfo Mango Pulp and Peel Beverages in Exercise

The aim of this study is to assess the antioxidant capacity of two mango base beverages (AM1, AM2), against exercise-induced oxidative stress.

Study Overview

Detailed Description

Introduction. The post-consumption physiological effect of mango cv. "Ataulfo" pulp (MP) and peel (MC) in humans before exercise has been poorly evaluated.

Objective. To evaluate the physiological response, to consumption of two mango base beverages, AM1 (200g MP/ 600mL water) and AM2 (160g MP; 40g MC / 600mL water), before and after a submaximal exercise test.

Methods. The antioxidant profile and physicochemical characteristics of AM1 and AM2 were evaluated. Several cardiorespiratory, anthropometric and body composition parameters of 19 university students, prior to the consumption of AM1, AM2 and water, were evaluated in three non-consecutive sessions (self-control cases). The glycemic, lactic and antioxidant (FRAP), uric acid (AU), reduced glutathione (GSH) and lipid oxidation (TBARS) and protein carbonyls (PC) responses were evaluated in plasma before and after an incremental cycle ergometer exercise test.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 28 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • healthy male
  • university student
  • no alcohol, cigar or drugs consumption

Exclusion Criteria:

  • no antioxidant supplement or ergogenic consumption
  • health issues with performing physical activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AM1
Mango pulp beverage

The subject consumes mango pulp beverage (200 g mango pulp + 600 mL water). 2 hours later subject performs the exercise test.

Washout: 1 week washout period prior to the administration of this intervention to avoid possible carryover effect.

Other Names:
  • AM1
  • 200 g mango pulp + 600 mL water
Experimental: AM2
Mango pulp and peel beverage

The subject consumes mango pulp and peel beverage (160 g mango pulp + 40 g mango peel + 600 mL water). 2 hours later subject performs the exercise test.

Washout: 1 week washout period prior to the administration of this intervention to avoid possible carryover effect.

Other Names:
  • AM2
  • 160 g mango pulp + 40 g mango peel + 600 mL water
Placebo Comparator: Control
Control beverage

The subject consumes control beverage (600 mL water). 2 hours later subject performs the exercise test.

Washout: 1 week washout period prior to the administration of this intervention to avoid possible carryover effect.

Other Names:
  • 600 mL water

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Antioxidant capacity change
Time Frame: 0 min (before beverage intake), 9-15 min (immediately after exercise test)
Assessed by FRAP change. Blood samples were drawn from the antecubital vein into EDTA test tubes at rest, before beverage intake, and immediately following the exercise test. Samples were then centrifuged at 5000 rpm for 10 min at 4°C to obtain plasma, which was withdrawn and separated into eppendorf vials, maintained at -80°C until further biochemical analysis.
0 min (before beverage intake), 9-15 min (immediately after exercise test)
Antioxidant capacity change
Time Frame: 0 min (before beverage intake), 9-15 (immediately after exercise test)
Assessed by uric acid concentration change. Blood samples were drawn from the antecubital vein into EDTA test tubes at rest, before beverage intake, and immediately following the exercise test. Samples were then centrifuged at 5000 rpm for 10 min at 4°C to obtain plasma, which was withdrawn and separated into eppendorf vials, maintained at -80°C until further biochemical analysis.
0 min (before beverage intake), 9-15 (immediately after exercise test)
Antioxidant capacity change
Time Frame: 0 min (before beverage intake), 9-15 (immediately after exercise test)
Assessed by reduced glutathione concentration change. Blood samples were drawn from the antecubital vein into EDTA test tubes at rest, before beverage intake, and immediately following the exercise test. Samples were then centrifuged at 5000 rpm for 10 min at 4°C to obtain plasma, which was withdrawn and separated into eppendorf vials, maintained at -80°C until further biochemical analysis.
0 min (before beverage intake), 9-15 (immediately after exercise test)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxidative stress change
Time Frame: 0 min (before beverage intake), 9-15 (immediately after exercise test)
Assessed by TBARS concentration change. Blood samples were drawn from the antecubital vein into EDTA test tubes at rest, before beverage intake, and immediately following the exercise test. Samples were then centrifuged at 5000 rpm for 10 min at 4°C to obtain plasma, which was withdrawn and separated into eppendorf vials, maintained at -80°C until further biochemical analysis.
0 min (before beverage intake), 9-15 (immediately after exercise test)
Oxidative stress change
Time Frame: 0 min (before beverage intake), 9-15 (immediately after exercise test)
Assessed by protein carbonyls concentration change. Blood samples were drawn from the antecubital vein into EDTA test tubes at rest, before beverage intake, and immediately following the exercise test. Samples were then centrifuged at 5000 rpm for 10 min at 4°C to obtain plasma, which was withdrawn and separated into eppendorf vials, maintained at -80°C until further biochemical analysis.
0 min (before beverage intake), 9-15 (immediately after exercise test)
Lactic acid concentration change
Time Frame: 0 min (before performing exercise test), 3 min, 6 min, 9 min, 12 min, 15 min (during exercise test)
Assessed by lactic acid concentration change. Capillary blood samples were taken from the fingertip, using a lancet and analyzed (YSI modelo 1500, Yellow Springs, USA)
0 min (before performing exercise test), 3 min, 6 min, 9 min, 12 min, 15 min (during exercise test)
Postprandial glycemic change
Time Frame: 0 min (before beverage intake), 30 min, 60 min, 90 min, 120 min (after beverage intake)
Assessed by blood glucose concentration change. Capillary blood samples were taken from the fingertip, using a lancet, and analyzed (ReliOn Confirm/micro Test Strips ARKRAY, USA)
0 min (before beverage intake), 30 min, 60 min, 90 min, 120 min (after beverage intake)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Abraham Wall-Medrano, PhD, Universidad Autonoma de Ciudad Juarez
  • Principal Investigator: Gregorio Chavez-Treviño, MS, Universidad Autonoma de Ciudad Juarez

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

February 28, 2017

Study Completion (Actual)

April 30, 2017

Study Registration Dates

First Submitted

May 29, 2017

First Submitted That Met QC Criteria

June 7, 2017

First Posted (Actual)

June 9, 2017

Study Record Updates

Last Update Posted (Actual)

June 9, 2017

Last Update Submitted That Met QC Criteria

June 7, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • UACJ-ICB-2017-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise-induced Oxidative Stress

Clinical Trials on Mango pulp beverage

3
Subscribe